Pecaut & Co’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Pecaut & Co’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,627	Closed	-$1.63M	–	73
2024 Q1	$1.63M	Buy	10,627 +446	+4%	+$68K	0.61%	31
2023 Q4	$1.61M	Buy	10,181 +1,341	+15%	+$193K	0.65%	31
2023 Q3	$1.29M	Buy	8,840 +65	+0.7%	+$9.9K	0.54%	36
2023 Q2	$1.34M	Buy	8,775 +663	+8%	+$103K	0.57%	34
2023 Q1	$1.26M	Buy	8,112 +167	+2%	+$26.2K	0.57%	37
2022 Q4	$1.22M	Buy	7,945 +977	+14%	+$144K	0.58%	35
2022 Q3	$920K	Buy	6,968 +338	+5%	+$47.4K	0.49%	41
2022 Q2	$899K	Buy	6,630 +1,086	+20%	+$150K	0.51%	40
2022 Q1	$827K	Buy	5,544 +197	+4%	+$29.1K	0.4%	41
2021 Q4	$866K	Buy	5,347 +2,684	+101%	+$434K	0.44%	40
2021 Q3	$442K	Buy	+2,663	New	+$455K	0.26%	49

Other funds holding FBT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Pecaut & Co's FBT Position: Q2 2024 in Review

Pecaut & Co sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2024, closing a stake of 10,627 shares — an estimated $1.63M sold.

Pecaut & Co first reported a position in FBT in Q3 2021 and held it in 11 quarters. The position peaked at $1.63M in Q1 2024. 251 funds tracked by Wall St. Rank hold FBT as of Q2 2024.

Pecaut & Co reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2024 after selling out during the quarter.
Pecaut & Co sold 10,627 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2024, an estimated $1.63M.
Pecaut & Co first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2021 and held it in 11 quarters.
Pecaut & Co's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.63M in Q1 2024.
251 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2024.

Based on Pecaut & Co's 13F filing for Q2 2024, filed 7 Aug 2024.